Literature DB >> 10383571

Trefoil peptides and surgical disease.

R J Longman1, M G Thomas, R Poulsom.   

Abstract

BACKGROUND: Trefoil peptides are a family of small proteins that are expressed in a site-specific fashion by certain epithelial tissues. These peptides appear to be important in mucosal healing processes and in neoplastic disease.
METHODS: This manuscript reviews the relevant literature obtained by an extensive text word search of the Medline database and a manual search of references from the articles identified. RESULTS AND
CONCLUSION: Trefoil peptides are aberrantly expressed by a wide range of human carcinomas and gastrointestinal inflammatory conditions. They impart protection from injury to the gastrointestinal mucosa by possible interaction with mucin glycoproteins. Trefoil peptides influence epithelial cell migration and mucosal restitution following injury. In the future, serum levels of trefoil peptides might be used as markers for both neoplastic and inflammatory diseases. In addition, novel therapies based on such peptides might be used for gastrointestinal inflammatory conditions and to accelerate repair of the gastrointestinal mucosa after surgery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383571     DOI: 10.1046/j.1365-2168.1999.01131.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  4 in total

1.  Proliferative response in necrotising enterocolitis is insufficient to prevent disease progression.

Authors:  Daniela Vieten; Anthony Corfield; Pramila Ramani; Richard Spicer
Journal:  Pediatr Surg Int       Date:  2006-01       Impact factor: 1.827

2.  Analysis of trefoil factor family protein 1 (TFF1, pS2) expression in chronic cholecystitis and gallbladder carcinoma.

Authors:  Peter Kornprat; Peter Rehak; Martina Lemmerer; Margit Gogg-Kamerer; Cord Langner
Journal:  Virchows Arch       Date:  2005-04-09       Impact factor: 4.064

3.  Impaired mucosal regeneration in neonatal necrotising enterocolitis.

Authors:  Daniela Vieten; Anthony Corfield; Daniel Carroll; Pramila Ramani; Richard Spicer
Journal:  Pediatr Surg Int       Date:  2004-12-02       Impact factor: 1.827

4.  Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer.

Authors:  Yuko Ishibashi; Hiroshi Ohtsu; Masako Ikemura; Yasuko Kikuchi; Takayoshi Niwa; Kotoe Nishioka; Yoshihiro Uchida; Hirona Miura; Susumu Aikou; Toshiaki Gunji; Nobuyuki Matsuhashi; Yasukazu Ohmoto; Takeshi Sasaki; Yasuyuki Seto; Toshihisa Ogawa; Keiichiro Tada; Sachiyo Nomura
Journal:  Sci Rep       Date:  2017-07-07       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.